MEA PCR-Based Transplant Diagnostics Market - Industry Trends and Forecast to 2034

Description

List of Tables

Middle East and Africa PCR based transplant diagnostics market is expected to reach USD 8,888.58 thousand by 2031, from USD 6,672.58 thousand in 2023 growing at the CAGR of 3.9% in the forecast period of 2024 to 2031.

Market Segmentation

Middle East and Africa PCR Based Transplant Diagnostics Market, By Test Type (CMV PCR Test, EBV PCR Test, BKV PCR Test, VZV PCR Test, HSV1 PCR TestHSV2 PCR Test, Parvovirus B19 PCR Test, P. Jirovecii PCR Test, JCV PCR Test, Adenovirus PCR Test, and Aspergillus Spp PCR Test), By Transplant Type (Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation, Pancreas Transplantation, and Other Transplantations), Application (Diagnostic Applications and Research Applications), End User (Hospitals and Transplant Centers, Commercial Service Providers, Research Laboratories and Academic Institutes), Country (South Africa, Saudi Arabia, U.A.E, Egypt, Israel, and Rest of Middle East and Africa )- Industry Trends and Forecast to 2031

Overview of Middle East and Africa PCR Based Transplant Diagnostics Market Dynamics

Driver
Increasing prevalence of organ failure
Restraint
Shortage of professionals with expertise in transplant diagnostics
Opportunity
Strategic initiation and technology launches by market players

Market Players

Some of the major market players for Middle East and Africa PCR based transplant diagnostics market are:

Quest Diagnostics Incorporated.
Dr Lal PathLabs

1 INTRODUCTION 12

1.1 OBJECTIVES OF THE STUDY 12
1.2 MARKET DEFINITION 12
1.3 OVERVIEW OF THE MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET 12
1.4 CURRENCY AND PRICING 13
1.5 LIMITATIONS 13
1.6 MARKETS COVERED 14

2 MARKET SEGMENTATION 16

2.1 MARKETS COVERED 16
2.2 GEOGRAPHICAL SCOPE 17
2.3 YEARS CONSIDERED FOR THE STUDY 18
2.4 DBMR TRIPOD DATA VALIDATION MODEL 19
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 22
2.6 MULTIVARIATE MODELLING 23
2.7 TEST TYPE SEGMENT LIFELINE CURVE 23
2.8 MARKET END USER COVERAGE GRID 24
2.9 DBMR MARKET POSITION GRID 25
2.10 VENDOR SHARE ANALYSIS 26
2.11 SECONDARY SOURCES 27
2.12 ASSUMPTIONS 27

3 EXECUTIVE SUMMARY 28

4 PREMIUM INSIGHTS 30

4.1 PESTAL ANALYSIS 31
4.2 PORTERS FIVE FORCES 32

5 MARKET OVERVIEW 33

5.1 DRIVERS 35
- 5.1.1 INCREASING PREVALENCE OF ORGAN FAILURE 35
- 5.1.2 RISING POPULARITY OF NON-INVASIVE DIAGNOSTIC METHODS 35
- 5.1.3 ADVANCEMENT IN ORGAN PRESERVATIVE TECHNIQUES 36
- 5.1.4 RISING PREVALENCE OF CHRONIC AND INFECTIOUS DISEASES 37
5.2 RESTRAINTS 38
- 5.2.1 SHORTAGE OF PROFESSIONALS WITH EXPERTISE IN TRANSPLANT DIAGNOSTICS 38
- 5.2.2 HIGH COST OF PCR/NGS SOFTWARE 38
5.3 OPPORTUNITIES 39
- 5.3.1 STRATEGIC INITIATION AND TECHNOLOGY LAUNCHES BY MARKET PLAYERS 39
- 5.3.2 RISE IN GOVERNMENT SUPPORT AND FUNDING FOR PCR-BASED ORGAN TRANSPLANTATION 39
- 5.3.3 SURGE OF AWARENESS FOR ORGAN TRANSPLANTATION 40
5.4 CHALLENGES 41
- 5.4.1 ETHICAL CHALLENGES FACED DURING ORGAN TRANSPLANTATION 41
- 5.4.2 LACK OF ORGAN DONORS AND PROVIDERS ANNUALLY 42

6 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE 43

6.1 OVERVIEW 44
6.2 CMV PCR TEST 48
6.3 EBV PCR TEST 48
6.4 BKV PCR TEST 48
6.5 VZV PCR TEST 49
6.6 HSV1 PCR TEST 50
6.7 HSV2 PCR TEST 50
6.8 PARVOVIRUS B19 PCR TEST 50
6.9 P. JIROVECII PCR TEST 51
6.10 JCV PCR TEST 52
6.11 ADENOVIRUS PCR TEST 52
6.12 ASPERGILLUS SPP PCR TEST 53

7 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE 54

7.1 OVERVIEW 55
7.2 KIDNEY TRANSPLANTATION 58
7.3 LIVER TRANSPLANTATION 59
7.4 HEART TRANSPLANTATION 59
7.5 LUNG TRANSPLANTATION 60
7.6 PANCREAS TRANSPLANTATION 60
7.7 OTHER TRANSPLANTATIONS 61

8 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 62

8.1 OVERVIEW 63
8.2 DIAGNOSTIC APPLICATIONS 66
8.3 RESEARCH APPLICATIONS 67

9 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER 68

9.1 OVERVIEW 69
9.2 HOSPITALS AND TRANSPLANT CENTERS 72
9.3 COMMERCIAL SERVICE PROVIDERS 73
9.4 RESEARCH LABORATORIES AND ACADEMIC INSTITUTES 73

10 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY 74

10.1 MIDDLE EAST AND AFRICA 76
- 10.1.1 SAUDI ARABIA 79
- 10.1.2 ISRAEL 81
- 10.1.3 EGYPT 83
- 10.1.4 SOUTH AFRICA 85
- 10.1.5 U.A.E. 87
- 10.1.6 REST OF MIDDLE EAST AND AFRICA 89

11 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, COMPANY LANDSCAPE 90

11.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA 90

12 SWOT ANALYSIS 91

13 COMPANY PROFILES 92

13.1 QUEST DIAGNOSTICS INCORPORATED. 92
- 13.1.1 COMPANY SNAPSHOT 92
- 13.1.2 REVENUE ANALYSIS 92
- 13.1.3 COMPANY SHARE ANALYSIS 93
- 13.1.4 PRODUCT PORTFOLIO 93
- 13.1.5 RECENT DEVELOPMENTS 94
13.2 LABORATORY CORPORATION OF AMERICA HOLDINGS. 95
- 13.2.1 COMPANY SNAPSHOT 95
- 13.2.2 REVENUE ANALYSIS 95
- 13.2.3 COMPANY SHARE ANALYSIS 96
- 13.2.4 PRODUCT PORTFOLIO 96
- 13.2.5 RECENT DEVELOPMENT 97
13.3 EUROFINS VIRACOR 98
- 13.3.1 COMPANY SNAPSHOT 98
- 13.3.2 COMPANY SHARE ANALYSIS 98
- 13.3.3 PRODUCT PORTFOLIO 99
- 13.3.4 RECENT DEVELOPMENTS 100
13.4 SONIC HEALTHCARE LIMITED 101
- 13.4.1 COMPANY SNAPSHOT 101
- 13.4.2 PRODUCT REVENUE ANALYSIS 101
- 13.4.3 COMPANY SHARE ANALYSIS 102
- 13.4.4 PRODUCT PORTFOLIO 102
- 13.4.5 RECENT DEVELOPMENTS 103
13.5 DR LAL PATHLABS. 104
- 13.5.1 COMPANY SNAPSHOT 104
- 13.5.2 REVENUE ANALYSIS 104
- 13.5.3 COMPANY SHARE ANALYSIS 105
- 13.5.4 PRODUCT PORTFOLIO 105
- 13.5.5 RECENT DEVELOPMENTS 106
13.6 ARUP LABORATORIES 107
- 13.6.1 COMPANY SNAPSHOT 107
- 13.6.2 PRODUCT PORTFOLIO 107
- 13.6.3 RECENT DEVELOPMENT 107
13.7 AMBAR LAB. 108
- 13.7.1 COMPANY SNAPSHOT 108
- 13.7.2 PRODUCT PORTFOLIO 108
- 13.7.3 RECENT DEVELOPMENTS 108

14 QUESTIONNAIRE 109

15 RELATED REPORTS 112

LIST OF TABLES

TABLE 1 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 47
TABLE 2 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 47
TABLE 3 MIDDLE EAST AND AFRICA CMV PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 48
TABLE 4 MIDDLE EAST AND AFRICA EBV PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 48
TABLE 5 MIDDLE EAST AND AFRICA BKV PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 49
TABLE 6 MIDDLE EAST AND AFRICA VZV PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 49
TABLE 7 MIDDLE EAST AND AFRICA HSV1 PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 50
TABLE 8 MIDDLE EAST AND AFRICA HSV2 PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 50
TABLE 9 MIDDLE EAST AND AFRICA PARVOVIRUS B19 PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 51
TABLE 10 MIDDLE EAST AND AFRICA P. JIROVECII PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 51
TABLE 11 MIDDLE EAST AND AFRICA JCV PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 52
TABLE 12 MIDDLE EAST AND AFRICA ADENOVIRUS PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 52
TABLE 13 MIDDLE EAST AND AFRICA ASPERGILLUS SPP PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 53
TABLE 14 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 58
TABLE 15 MIDDLE EAST AND AFRICA KIDNEY TRANSPLANTATION IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 58
TABLE 16 MIDDLE EAST AND AFRICA LIVER TRANSPLANTATION IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 59
TABLE 17 MIDDLE EAST AND AFRICA HEART TRANSPLANTATION IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 59
TABLE 18 MIDDLE EAST AND AFRICA LUNG TRANSPLANTATION IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 60
TABLE 19 MIDDLE EAST AND AFRICA PANCREAS TRANSPLANTATION IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 60
TABLE 20 MIDDLE EAST AND AFRICA OTHER TRANSPLANTATION IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 61
TABLE 21 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 66
TABLE 22 MIDDLE EAST AND AFRICA DIAGNOSTIC APPLICATION IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 66
TABLE 23 MIDDLE EAST AND AFRICA RESEARCH APPLICATION IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 67
TABLE 24 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 72
TABLE 25 MIDDLE EAST AND AFRICA HOSPITALS AND TRANSPLANT CENTERS IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 72
TABLE 26 MIDDLE EAST AND AFRICA COMMERCIAL SERVICE PROVIDERS IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 73
TABLE 27 MIDDLE EAST AND AFRICA RESEARCH LABORATORIES AND ACADEMIC INSTITUTES IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 73
TABLE 28 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND) 76
TABLE 29 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 76
TABLE 30 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 77
TABLE 31 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 77
TABLE 32 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 77
TABLE 33 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 78
TABLE 34 SAUDI ARABIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 79
TABLE 35 SAUDI ARABIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 79
TABLE 36 SAUDI ARABIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 80
TABLE 37 SAUDI ARABIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 80
TABLE 38 SAUDI ARABIA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 80
TABLE 39 ISRAEL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 81
TABLE 40 ISRAEL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 81
TABLE 41 ISRAEL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 82
TABLE 42 ISRAEL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 82
TABLE 43 ISRAEL PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 82
TABLE 44 EGYPT PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 83
TABLE 45 EGYPT PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 83
TABLE 46 EGYPT PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 84
TABLE 47 EGYPT PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 84
TABLE 48 EGYPT PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 84
TABLE 49 SOUTH AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 85
TABLE 50 SOUTH AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 85
TABLE 51 SOUTH AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 86
TABLE 52 SOUTH AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 86
TABLE 53 SOUTH AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 86
TABLE 54 U.A.E. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 87
TABLE 55 U.A.E. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 87
TABLE 56 U.A.E. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 88
TABLE 57 U.A.E. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 88
TABLE 58 U.A.E. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 88
TABLE 59 REST OF MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 89
TABLE 60 REST OF MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 89

LIST OF FIGURES

FIGURE 1 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: SEGMENTATION 16
FIGURE 2 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: DATA TRIANGULATION 19
FIGURE 3 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: DROC ANALYSIS 20
FIGURE 4 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: MIDDLE EAST AND AFRICA VS REGIONAL MARKET SHARE ANALYSIS 21
FIGURE 5 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS 21
FIGURE 6 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS 22
FIGURE 7 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: MARKET END USER COVERAGE GRID 24
FIGURE 8 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID 25
FIGURE 9 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: VENDOR SHARE ANALYSIS 26
FIGURE 10 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: SEGMENTATION 29
FIGURE 11 INCREASING PREVALENCE OF ORGAN FAILURE IS EXPECTED TO DRIVE THE GROWTH OF THE MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET FROM 2024 TO 2034 30
FIGURE 12 CMV PCR TEST SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET IN 2024 TO 2031 30
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET 34
FIGURE 14 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY TEST TYPE, 2023 44
FIGURE 15 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY TEST TYPE, 2024-2031 (USD THOUSAND) 45
FIGURE 16 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY TEST TYPE, CAGR (2024-2031) 45
FIGURE 17 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY TEST TYPE LIFELINE CURVE 46
FIGURE 18 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY TRANSPLANT TYPE, 2023 55
FIGURE 19 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY TRANSPLANT TYPE, 2024-2031 (USD THOUSAND) 56
FIGURE 20 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY TRANSPLANT TYPE, CAGR (2024-2031) 56
FIGURE 21 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY TRANSPLANT TYPE, LIFELINE CURVE 57
FIGURE 22 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY APPLICATION, 2023 63
FIGURE 23 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY APPLICATION, 2024-2031 (USD THOUSAND) 64
FIGURE 24 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: APPLICATION, CAGR (2024-2031) 64
FIGURE 25 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY APPLICATION, LIFELINE CURVE 65
FIGURE 26 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY END USER, 2023 69
FIGURE 27 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY END USER, 2024-2031 (USD THOUSAND) 70
FIGURE 28 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY END USER, CAGR (2024-2031) 70
FIGURE 29 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY END USER, LIFELINE CURVE 71
FIGURE 30 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: SNAPSHOT (2023) 75
FIGURE 31 MIDDLE EAST AND AFRICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: COMPANY SHARE 2023 (%) 90